| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |